Tag: AbbVie

Zydus Lifesciences, Daewoong Pharmaceutical forge US market alliance for Leuprolide Acetate

businessnewstoday- December 11, 2023

Zydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd., and South Korea's Daewoong Pharmaceutical Co., Ltd. have entered into a significant exclusive licensing agreement. ... Read More

AbbVie to acquire Cerevel Therapeutics for $8.7bn to expand neuroscience research

businessnewstoday- December 7, 2023

AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) have announced a definitive agreement in which AbbVie will acquire Cerevel Therapeutics. The transaction, valued at ... Read More

AbbVie to acquire ImmunoGen for $10.1bn to expand oncology portfolio

businessnewstoday- December 1, 2023

AbbVie Inc. and ImmunoGen Inc. have entered into a definitive agreement, marking a significant move in the pharmaceutical industry. AbbVie will acquire ImmunoGen, including its ... Read More

ABBV-RGX-314 : REGENXBIO reports positive Phase 2 data on diabetic retinopathy gene therapy candidate

businessnewstoday- November 4, 2023

REGENXBIO Inc. has disclosed new findings from its Phase II ALTITUDE trial, focusing on ABBV-RGX-314 as a gene therapy for diabetic retinopathy (DR) treatment. This ... Read More

AbbVie, Calibr to drive preclinical and clinical advancements in expanded partnership

businessnewstoday- July 26, 2023

AbbVie and Scripps Research institute’s division Calibr have announced a broadened strategic collaboration targeted at developing preclinical and early-stage clinical assets across a host of ... Read More

Caplin Point to tap into $35m market after FDA approval for NIMBEX generic

businessnewstoday- June 13, 2023

Caplin Steriles, a subsidiary of India's Caplin Point Laboratories, has obtained final approval from the US Food and Drug Administration (FDA) for its generic version ... Read More

Genmab gets EPKINLY FDA approval for diffuse large B-cell lymphoma

businessnewstoday- May 21, 2023

Danish biotech company Genmab has secured accelerated approval for EPKINLY (epcoritamab-bysp) from the US Food and Drug Administration (FDA) for the treatment of relapsed or ... Read More

AbbVie bags RINVOQ FDA approval for nr-axSpA in adults

businessnewstoday- October 22, 2022

RINVOQ FDA approval for nr-axSpA : AbbVie has bagged approval for its selective JAK inhibitor RINVOQ (upadacitinib 15 mg, once daily) from the US Food ... Read More

AbbVie acquires UK biotech company DJS Antibodies for $255m

Raghuram Kadari- October 21, 2022

AbbVie has acquired DJS Antibodies, a privately-held UK-based biotech company, in an all-cash transaction valued at approximately $255 million, in a move to further strengthen ... Read More

Harpoon Therapeutics gets FDA fast track status for HPN217 in RRMM

pallavi123- March 5, 2022

Harpoon Therapeutics has bagged fast track designation for HPN217 from the US Food and Drug Administration (FDA) for the treatment of certain patient population with ... Read More